Sartorius Stedim Biotech (SSB) and G-Con have entered a global collaboration to offer highly advanced and flexible production platforms for biopharmaceutical manufacturing. The new product line will leverage G-Con’s modular, mobile clean-room “pods” and SSB’s broad single-use and reusable product portfolio to create an integrated production process platform.

SSB has incorporated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography and viral clearance for biopharmaceutical development and manufacturing. The combined technology will, according to the companies, provide the industry with an unparalleled set of cost-effective, “plug and play” tools for next-generation manufacturing facilities.

Maik Jornitz, SSB’s senior vice president of marketing for Bioprocess Solutions, said, “The combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured. Our Integrated Solutions unit will implement G-Con’s platform of modular clean-room systems into their designs. In addition, our teams will benefit from G-Con’s engineering and design expertise. Our vision is to create standardized unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process.”

G-Con’s modular containment units are now available through SSB’s Integrated Solutions unit and will be launched globally in early 2012.